Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Safety and Efficacy of γδ T Cell Against Gastric Cancer [Phase 1, Phase 2]
A clinical trial update reports safety and efficacy data for γδ T cell therapy targeting gastric cancer in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: POF Versus FOLFOX Plus IP Paclitaxel in AGC [Phase 2]
Phase 2 clinical trial comparing POF regimen versus FOLFOX plus IP paclitaxel in advanced gastric cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer [Phase 2]
Phase 2 neoadjuvant POF regimen trial for locally advanced gastric cancer is in progress with unknown status.
-
FDA approval · 2019-10-25FDA Approved: KANJINTI — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for KANJINTI (trastuzumab-anns) submitted by Amgen, Inc. The action represents a regulatory approval…
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer [Phase 3]
A randomized Phase III trial comparing POF with SOX/CAPOX/FOLFOX as postoperative adjuvant chemotherapy for curatively resected stage III ga…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-10-10FDA Approved: CAPECITABINE 150MG — Supplemental Application (Armas Pharmaceuticals Inc.)
The FDA approved a supplemental application to add a 150 mg strength of capecitabine, manufactured by Armas Pharmaceuticals Inc., expanding …
-
FDA approval · 2019-10-09FDA Approved: CAPECITABINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for Capecitabine (CAPECITABINE) from Ascend Laboratories, LLC under ANDA207652.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer [Phase 3]
A Phase 3 trial comparing Low-Tox vs Eox in locally advanced unresectable or metastatic gastric cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating oxaliplatin, capecitabine, and trastuzumab with chemoradiotherapy as adjuvant therapy in operable HER2-positive gas…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: 64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer [NA]
Clinical trial evaluating 64Cu DOTA-Trastuzumab PET/CT imaging in patients with gastric cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma [Phase 2]
Phase 2 trial evaluating capecitabine, carboplatin, and bevacizumab for gastroesophageal junction and gastric cancer has completed, with res…
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Apatinib Plus Sintilimab in Advanced Gastric Cancer Refractory to at Least Two Previous Chemotherapy Regimens [Phase 2]
Phase 2 trial evaluating apatinib plus sintilimab in advanced gastric cancer that is refractory to at least two prior chemotherapies.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis [Phase 3]
Phase 3 clinical trial evaluating cytoreductive surgery with HIPEC and chemotherapy for gastric cancer with peritoneal metastasis.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer [Phase 2]
A phase 2 trial evaluating FDG-PET directed treatment for locally advanced gastric and gastroesophageal junction adenocarcinoma was terminat…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Cancer [Phase 2]
Phase 2 trial assessing a chemotherapy combination (cisplatin-fluorouracil-afatinib) in patients with inoperable gastric or gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy [Phase 4]
A Phase 4 trial comparing berberine-amoxicillin quadruple therapy to tetracycline-furazolidone quadruple therapy for Helicobacter pylori-rel…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial update of S1201 evaluating combination chemotherapy for advanced or metastatic esophageal, gastric, or gastroesophageal juncti…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Gastrectomy, Eating Behaviour and GLP-1 [NA]
Completed clinical trial examining gastrectomy, eating behavior, and GLP-1 related to gastric cancer and dumping syndrome; results posted in…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer [Phase 1, Phase 2]
Phase 1/2 study updates on ramucirumab plus nivolumab in gastric and GEJ cancer completed.
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer [Phase 1, Phase 2]
A clinical trial evaluating gentuximab plus paclitaxel in advanced gastric or gastroesophageal junction cancer is in Phase 1/2 with status c…
-
CLINICAL_TRIALS trial_result · 2019-07-25Clinical Trial Update: Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer [Phase 2]
Phase 2 trial update for Neo-adjuvant chemotherapy in locally advanced gastric cancer (Stage T3-4NxM0) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer [Phase 2]
Phase 2 exploratory study update evaluating paclitaxel + S-1 + oxaliplatin (PSOX) for locally advanced or advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer [Phase 2]
Phase 2 translational study evaluating single-agent olaparib for advanced oesophagogastric cancer. The trial status is unspecified.
-
FDA approval · 2019-06-28FDA Approved: OGIVRI — Supplemental Application (Biocon Biologics Inc.)
FDA approved a supplemental Biologics License Application for OGIVRI (trastuzumab-dkst) from Biocon Biologics Inc., updating its labeling/pe…
-
CLINICAL_TRIALS trial_result · 2019-06-28Clinical Trial Update: Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer [Phase 2]
Phase 2 trial investigating apatinib combined with XELOX as neoadjuvant therapy for locally advanced gastric cancer.